Skip to main content
EKSO
NASDAQ Technology

Ekso Bionics to Become ChronoScale Corp. via Reverse Merger, Existing Shareholders Face 97% Dilution

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Technology
Sentiment info
Negative
Importance info
9
Price
$10.69
Mkt Cap
$37.558M
52W Low
$2.73
52W High
$13.5
52W Position info
292% above low
Off High info
21% below high
Rel. Volume
Market data snapshot near publication time

EKSO has more than doubled off its 52-week low of $2.73.

Summary

Ekso Bionics shareholders approved a reverse merger with Applied Digital Cloud Corporation, resulting in 97% dilution for existing shareholders and a pivot to AI cloud services under the new name ChronoScale Corporation.


Key Events · Financing and Capital Events · EKSO

  • Reverse Merger Approved

    Shareholders approved a business combination where Ekso Bionics will acquire Applied Digital Cloud Corporation ('Cloud'), a subsidiary of Applied Digital Corporation, in exchange for 138,216,820 newly issued shares of Ekso common stock.

  • Massive Shareholder Dilution

    Existing Ekso Bionics shareholders are expected to collectively hold approximately 3% of the combined company, ChronoScale Corporation, post-merger, representing a 97% dilution.

  • Company Rebranding and Business Pivot

    Ekso Bionics Holdings, Inc. will be renamed 'ChronoScale Corporation' and will shift its primary business focus from exoskeletons to AI cloud services, trading under a new ticker symbol 'CHRN'.

  • New Majority Owner and Board Control

    Applied Digital Corporation, through its subsidiary, will own approximately 96% of ChronoScale Corporation and will have the right to designate four out of seven directors, establishing it as a 'controlled company'.


Analysis · EKSO · Technology

This filing details the definitive terms of a reverse merger that will fundamentally transform Ekso Bionics. While a 97% dilution was previously indicated in the company's 10-K, this PREM14C provides the crucial specifics and formal shareholder approval for the transaction. Existing shareholders will see their ownership reduced to approximately 3% of the combined entity, ChronoScale Corporation, which will pivot from exoskeletons to AI cloud services. The transaction addresses the company's previously disclosed 'going concern' warning by bringing in new capital and a new business, but at a severe cost to current equity holders through massive dilution and a loss of control to Applied Digital Corporation, which will hold 96% of the new company and control the board. This marks a complete change in the company's business model and ownership structure.

At the time of this filing, EKSO was trading at $10.69 on NASDAQ in the Technology sector, with a market capitalization of approximately $37.6M. The 52-week trading range was $2.73 to $13.50. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EKSO - Latest Insights

EKSO
May 05, 2026, 5:10 PM EDT
Filing Type: 8-K/A
Importance Score:
10
Price at Filing: $12.00
Real-time Price: $12.00 info
Change: $0 (0%) info
Market Cap: $42.048M info
EKSO
May 04, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $11.95
Real-time Price: $12.00 info
Change: +$0.050 (+0.42%) info
Market Cap: $42.048M info
EKSO
Apr 28, 2026, 5:21 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $11.21
Real-time Price: $12.00 info
Change: +$0.790 (+7%) info
Market Cap: $42.048M info
EKSO
Apr 03, 2026, 5:05 PM EDT
Filing Type: DEF 14C
Importance Score:
9
Price at Filing: $9.27
Real-time Price: $12.00 info
Change: +$2.73 (+29%) info
Market Cap: $42.048M info
EKSO
Apr 02, 2026, 8:08 PM EDT
Filing Type: PRER14C
Importance Score:
9
Price at Filing: $9.27
Real-time Price: $12.00 info
Change: +$2.73 (+29%) info
Market Cap: $42.048M info